Amount and certainty of evidence in Cochrane systematic reviews of interventions: a large-scale meta-research study
Starck, T.; Ravaud, P.; Boutron, I.
Show abstract
ObjectivesTo quantify the amount and certainty of evidence in Cochrane systematic reviews of interventions, and to describe how this evidence has evolved over time. DesignLarge-scale meta-research study Data sourceCochrane Database of Systematic Reviews (search date April 8, 2025) Eligibility criteriaCochrane systematic reviews assessing interventions reporting "Summary of findings" tables. Data extractionData were automatically extracted using web scraping and a large language model, with quality control performed by humans on a random sample. AnalysisWe describe the certainty of evidence for each population-intervention-comparison-outcome (PICO) question reported in all Cochrane "Summary of findings" tables. When available, we compared the certainty of evidence between the initial version and the latest update. ResultsWe identified 5,116 reviews that reported a "Summary of findings" table, containing 64,849 PICO questions. Overall, 24% (n = 15,768) of PICOs had no study included, 31% (n = 20,390) included only 1 study, 14% (n = 8,796) 2 studies, and 31% (n = 19,895) more than 2 studies. Nearly all PICOs (97%) only included randomized trials. The median [Q1-Q3] number of included participants was 123 [0-557]. The certainty of evidence was rated as high for 4% (n = 2,852), moderate for 16% (n = 10,574), low for 27% (n = 17,409), very low for 26% (n = 17,012), and not assessed for 26% (n = 17,002). Of the 7,461 PICO questions with an update (median time to update of 4.3 years [Q1-Q3: 2.6-6.4]), the number of included studies in the latest update remained the same for 63%; the certainty of evidence was unchanged for 71%; upgraded for 13% and downgraded for 15%. ConclusionThe amount and certainty of evidence is low and has not improved over time with review updates. These results question the efficiency of the research ecosystem. SummaryO_ST_ABSWhat is already known on this topicC_ST_ABSO_LIHigh quality up-to-date evidence synthesis is essential for decision-makers. C_LIO_LIConfidence in the evidence informing decision-making can be limited by the amount and quality of primary research on a specific research question C_LI What this study addsO_LIThis large-scale meta-research study analyzed all Cochrane "Summary of findings" tables (i.e., 64,849 population-intervention-comparison-outcome - PICO - questions), and found that about two thirds of the PICO questions were informed by two or fewer studies, with a median [Q1-Q3] of 123 [0-557] participants per PICO; the associated certainty of evidence was rated as high in only 4% of the cases. C_LIO_LIAfter an update of the review (i.e., 7,461 PICOs), 63% PICOs did not include additional studies, and 71% showed no change in certainty of evidence; upgrades and downgrades of certainty occurred at similar frequencies. C_LIO_LIThese results question the efficiency of the research ecosystem. C_LI
Matching journals
The top 1 journal accounts for 50% of the predicted probability mass.
Similar papers in this journal
- Exploring the potential of Claude 2 for risk of bias assessment: Using a large language model to assess randomized controlled trials with RoB 2 97%
- Evaluation of the sensitivity, accuracy and currency of the Cochrane COVID-19 Study Register for supporting rapid evidence synthesis production 97%
- Development of a search filter to retrieve reports of interrupted time series studies from MEDLINE and PubMed 96%
Similar papers in this journal
- Updating the PRISMA reporting guideline for network meta-analysis: a scoping review 97%
- Characteristics and completeness of reporting of systematic reviews of prevalence studies in adult populations: a meta-epidemiological study 96%
- Methods used to select results to include in meta-analyses of nutrition research: a meta-research study 96%
Similar papers in this journal
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 92%
- Repurposing Existing Medications for Coronavirus Disease 2019: Protocol for a Rapid and Living Systematic Review 92%
- To Include or Not to Include? A prescription from the pharmacy on how to use active learning assisted screening in systematic reviews 92%
Similar papers in this journal
- Exploring scalable assessment methods for terminated trials in ClinicalTrials.gov: A cohort analysis of German and Californian trials 93%
- Modelling the impact of behavioural interventions during pandemics: A systematic review 92%
- How Informative Were Early SARS-CoV-2 Treatment and Prevention Trials? A longitudinal cohort analysis of trials registered on clinicaltrials.gov 92%
Similar papers in this journal
- Tool to assess risk of bias due to missing evidence in network meta-analysis (ROB-MEN): elaboration and examples 96%
- Transparency and reporting characteristics of COVID-19 randomized controlled trials 95%
- Evidence of unexplained discrepancies between planned and conducted statistical analyses: a review of randomized trials 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.